In a landmark clinical investigation, Zarifkar et al. (2017) enrolled medication-naïve patients with newly diagnosed type 2 diabetes mellitus and measured serum orexin-A levels alongside insulin resistance indices. This evidence concerns the gene HCRT and type 2 diabetes mellitus.